PDE5 inhibitor

2 marketed 5 in Phase 3

This page covers all PDE5 inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A, High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A, Multidrug resistance-associated protein 5, Phosphodiesterase type 5 (PDE5), PDE5 (phosphodiesterase type 5).

Targets

Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A, High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A, Multidrug resistance-associated protein 5 · Phosphodiesterase type 5 (PDE5) · PDE5 (phosphodiesterase type 5) · PDE5 (phosphodiesterase 5) · PDE5

Marketed (2)

Phase 3 pipeline (5)